Stock Events

Stock Events

Halozyme Therapeutics (RV7.STU) Q2 2026 Earnings

11MayConfirmed

Q1 2026

Q2 2026

-0.2

0.48

1.17

1.85

Details

Expected EPS

1.3116895499999999

Actual EPS

1.358384

Surprise EPS

0.05

Surprise Percent

+3.56%

Description

Halozyme Therapeutics (RV7.STU) has reported earnings of 1.358384 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.